Provider Portal
Provider Login
Interested in a provider account? Get started
Collection Instructions
Science and Research
For Provider
Cutting Edge Technology
Proprietary 3Dense
microchip technology
platform with Microarrays
and Mass Spectrometry
Our Tests
Get to the root of complex
health puzzles with the most
advanced functional testing
Help center
Explore our comprehensive
knowledge base
Patient navigation System
Patient Login
Make Payment
Track Kit Status
Help Center
For Patient
Collection Instructions
Simple At-home Collection
instructions and videos
Our Tests
Explore our Test menu for a
comprehensive offering of
advanced Wellness testing
Blood Draw Locations
Schedule and get your blood
drawn at a draw center or
from a mobile phlebotomist
Cutting Edge Technology
Proprietary 3Dense
microchip technology
platform with Microarrays
and Mass Spectrometry.
Science and Research
Research featured in peer-
reviewed publications with
renowned international
Advanced Software
Creative software solutions
to improve efficiency.
About Us
Our expert team that guides
our path and your Wellness.
View our certifications,
licenses, and compliance
Join the lab tech revolution
and change the face of
health & wellness
Test Category
Gut Health
Food Reaction
Cardiovascular Health
Neural Health
Search Test Menu
Science and Research
Test for Neural Health
The nervous system is responsible for controlling and coordinating bodily functions such as movement, sensation, cognition, and emotion, meaning that any damage or dysfunction to the nervous system can significantly impact a person's health and daily activities. Preserving optimal neural health is crucial in preventing cognitive decline and reducing the likelihood of neurodegenerative diseases.1
Neural health testing enables early detection of potential neural health issues, monitoring over time, and personalized interventions, making it essential for maintaining good neural health.
Vibrant Wellness provides the Neural Zoomer Plus Test, which evaluates reactivity to neurological antigens associated with various neurologically related diseases.
Choose a Neural Health Test to get started
Neural Zoomer Plus
Measures immune reactivity to structures, tissues, cells, and chemicals in the brain and peripheral nervous system
Learn More
Neural health and longevity

Neural health gradually deteriorates with age, resulting in structural and neurophysiological alterations as well as a reduction in cognitive ability.3 During aging, the neural cellular environment exhibits evidence of compromised bioenergetics, impaired adaptive neuroplasticity, and a vulnerability to excessive neural activity. This results in the accumulation of damaged neural molecules and organelles, inflammation, and a loss of cognitive abilities, all of which have been shown to affect longevity.3,4 

Clinical Consultants
Dr. Stojan Peric
Dr. Stojan Peric, MD, Ph.D. is a teaching assistant and neurologist at the Neurology Clinic, University Clinical Center of Serbia. His research interests include various aspects of clinical neurology, including movement disorders, neuromuscular diseases, neuroimmunology, and neuro-ophthalmology. Dr. Peric investigated the functional and morphological impairments of the central nervous system in patients with myotonic dystrophy type1. Dr. Stojan Peric's mission is to advance the field of neurology through rigorous research that examines both the clinical and basic aspects of neuromuscular diseases. His research seeks to deepen our understanding of the underlying mechanisms that contribute to neurological diseases and identify potential therapeutic targets for their treatment.5
Expert opinions 
Dr. Marilyn Albert
Dr. Marilyn Albert, Ph.D. is a professor of Neurology at Johns Hopkins, and Director of the Division of Cognitive Neuroscience, USA. Dr. Albert focuses on the cognitive and brain changes associated with aging and Alzheimer’s disease (AD). She has also identified lifestyle factors that promote the maintenance of mental abilities with advancing age. In one of her papers, she mentions that the changes in cognition are associated with aging and with neurodegenerative disorders, particularly AD. Understanding the cognitive and brain changes associated with aging might provide information to improve early diagnosis. Dr. Albert believes that focusing on the early identification of AD, and potential ways of monitoring the progression of the disease is needed for its early intervention.6
Our Publications, Patents, & Clinical Trials
Methods, systems, and arrays for biomolecular analysis’ and ‘Substrates, peptide arrays, and methods
Our patents, ‘Methods, systems, and arrays for biomolecular analysis’ and ‘Substrates, peptide arrays, and methods’ disclose the methods for manufacturing and using the formulations, substrates, and arrays. This technology can be employed to identify neural peptide sequences useful for the diagnosis and treatment of various neurological disorders.
Jack Jr, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., ... & Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet Neurology, 9(1), 119-128.
Thompson, F. M. (2023). Mental Health and Neurology. The Liver in Systemic Disease: A Clinician's Guide to Abnormal Liver Tests, 201-208.
Bishop, N. A., Lu, T., & Yankner, B. A. (2010). Neural mechanisms of ageing and cognitive decline. Nature, 464(7288), 529-535.
Peters, R. (2006). Ageing and the brain. Postgraduate medical journal, 82(964), 84-88.
Basta, I., Delic, N., Gunjic, I., Arsenijevic Zdraljevic, M., Kacar, A., Bozovic, I., & Peric, S. (2023). Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia. Journal of the Peripheral Nervous System.
Bakker, A., Krauss, G. L., Albert, M. S., Speck, C. L., Jones, L. R., Stark, C. E., ... & Gallagher, M. (2012). Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron, 74(3), 467-474.
Chung, C. Y., Khurana, V., Auluck, P. K., Tardiff, D. F., Mazzulli, J. R., Soldner, F., ... & Lindquist, S. (2013). Identification and rescue of α-synuclein toxicity in Parkinson patient–derived neurons. Science, 342(6161), 983-987.
One lab one box
Intuitive interactive reporting
Subscribe to our newsletter !
Get the latest product and company updates
VW logo
3521 Leonard Ct, Santa Clara, CA 95054
For Patients
For Providers
Our Tests
About Us
Contact Us
Vibrant Functional Academy
Science and Research
Help Center
Terms of Use
Privacy Policy
Testing Policy
Billing Information
© 2023 Vibrant lab All right reserved